Evidence map›Paper›PMID 20980604›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2010

Thermally active TRPV1 tonically drives central spontaneous glutamate release.

Kiyomitsu Shoudai, James H Peters, Stuart J McDougall, Jessica A Fawley, Michael C Andresen

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 110 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Toxic Peptide FromFrontiers in pharmacology · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Insights into Potential Targets for Therapeutic Intervention in Epilepsy.International journal of molecular sciences · 2020
    Review
  18. Review
  19. 5-HTBrain research · 2019
    Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kiyomitsu ShoudaiDepartment of Physiology and Pharmacology, Oregon Health and Science University, Portland, Oregon 97239, USA.
James H Peters
Stuart J McDougall
Jessica A Fawley
Michael C Andresen
Oregon Health & Science University · US

Funding

Transmission Across the First Synapse of the BaroreflexR01HL041119 · NHLBI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI ANDRESEN, MICHAEL CHRISTIAN · 1991 to 2009
$2.9M
Central TRPV1 in Cardiovascular RegulationR01HL105703 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ANDRESEN, MICHAEL CHRISTIAN · 2011 to 2014
$1.5M
Presynaptic Mechanisms of Neurotransmission in NTSR01HL083115 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ANDRESEN, MICHAEL CHRISTIAN · 2006 to 2009
$1.4M
Oxytocin enhances afferent synaptic transmission within the NTS.F32HL088894 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI PETERS, JAMES HENRY · 2007 to 2009
$137k
NHLBI NIH HHS F32 HL088894NHLBI NIH HHS HL-41119NHLBI NIH HHS HL-88894NHLBI NIH HHS R01 HL041119NHLBI NIH HHS R01 HL083115NHLBI NIH HHS R01 HL105703
6 · The paper itself

Abstract

Central synapses spontaneously release neurotransmitter at low rates. In the brainstem, cranial visceral afferent terminals in caudal solitary tract nucleus (NTS) display pronounced, activity-dependent, asynchronous release of glutamate and this extra release depends on TRPV1 receptors (TRPV1+). Asynchronous release is absent for afferents lacking TRPV1 (TRPV1-) and resting EPSC frequency was greater in TRPV1+. Here, we studied this basal activity difference by assessing thermal sensitivity of spontaneous and miniature synaptic events in TRPV1+ and TRPV1- second-order NTS neurons. The spontaneous EPSC rate decreased when temperature was decreased, increased steeply between 30 and 42°C only in TRPV1+ neurons, and was calcium-dependent. TRPV1-specific antagonist SB366791, but not TTX, strongly attenuated thermal responses. Temperature changes failed to alter EPSC frequency in TRPV1- neurons. EPSC amplitudes and decay kinetics changed little with temperature. IPSCs in these second-order NTS neurons were unaltered by temperature. Such results suggest that activated, presynaptic TRPV1+ receptors trigger continuous resting release of glutamate vesicles at physiological temperatures only in capsaicin-responsive terminals. In mechanically isolated individual neurons harvested from medial NTS, increases in temperature increased the rate of glutamate release only in TRPV1+ neurons, whereas IPSC rates were unaffected. Cadmium failed to block thermal increases in glutamate release, suggesting that calcium entry through TRPV1 channels may trigger glutamate release independently of voltage-activated calcium channels. Together, our findings indicate a new form of afferent signaling in which TRPV1 channels within central terminals of peripheral afferents tonically generate glutamate release in NTS at 37°C in the absence of afferent action potentials.

Indexed as

Action PotentialsAnilidesAnimalsCadmium CompoundsCalciumCapsaicinCinnamatesExcitatory Postsynaptic Potentialsgamma-Aminobutyric AcidGlutamic AcidMaleNeurons, AfferentRatsRats, Sprague-DawleySignal TransductionSodium Channel BlockersAnilidesCadmium CompoundsCalciumCapsaicinCinnamatesgamma-Aminobutyric AcidGlutamic AcidN-(3-methoxyphenyl)-4-chlorocinnamanilideSodium Channel BlockersTetrodotoxinTrpv1 protein, ratTRPV1 receptorTRPV Cation Channels

Identifiers

PMID20980604
PMCPMC2976575
OpenAlexW2008048120

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.